The efficacy of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) is not well defined. This study examines the variables that may determine the outcome of OLT for HCC in HCV patients. From 1990 to 1999, 463 OLTs were performed for HCV c
Survival after liver transplantation for hepatocellular carcinoma
β Scribed by A Khakhar; E Solano; D Stell; M Bloch; C Dale; P Burns; C Ghent; D Quan; V McAlister; P Marotta; W.J Wall
- Book ID
- 116929196
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 75 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of
It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo